Skip to Content
Merck

T48402

2,2,2-Tribromoethanol

97%

Synonym(s):

Tribromoethyl alcohol

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
Br3CCH2OH
CAS Number:
Molecular Weight:
282.76
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
200-903-1
Beilstein/REAXYS Number:
1733249
MDL number:
Assay:
97%
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Level

assay

97%

bp

92-93 °C/10 mmHg (lit.)

mp

73-79 °C (lit.)

SMILES string

OCC(Br)(Br)Br

InChI

1S/C2H3Br3O/c3-2(4,5)1-6/h6H,1H2

InChI key

YFDSDPIBEUFTMI-UHFFFAOYSA-N

General description

2,2,2-Tribromoethanol is generally used as an anesthetic drug for rodents.

Application

2,2,2-Tribromoethanol can be used as a functional initiator for the introduction of α-hydroxyl groups to poly(methyl methacrylate) and poly(n-butyl acrylate).


pictograms

Exclamation mark

signalword

Warning

Hazard Classifications

Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



R J Scott Lacombe et al.
Journal of lipid research, 58(10), 2071-2081 (2017-07-12)
DHA (22:6n-3) may be derived from two dietary sources, preformed dietary DHA or through synthesis from α-linolenic acid (ALA; 18:3n-3). However, conventional methods cannot distinguish between DHA derived from either source without the use of costly labeled tracers. In the
Chanyoung Song et al.
Nature communications, 10(1), 3745-3745 (2019-08-23)
The low response rate of current cancer immunotherapy suggests the presence of few antigen-specific T cells and a high number of immunosuppressive factors in tumor microenvironment (TME). Here, we develop a syringeable immunomodulatory multidomain nanogel (iGel) that overcomes the limitation
Efficacy of Tribromoethanol.
Papaioannou VE & Fox JG
Laboratory Animal Science, 43(2) (1993)